Sutro Biopharma (STRO) Treasury Shares (2016 - 2026)
Sutro Biopharma (STRO) posted Treasury Shares of $417772.0 for Q4 2025, down 92.02% sequentially from $5.2 million in Q3 2025, and down 29.87% YoY from $595691.0 in Q4 2024.
Sutro Biopharma (STRO) Treasury Shares (2016 - 2026) Analysis & Trends
Sutro Biopharma has reported Treasury Shares for 10 years, with the latest figure at $417772.0 in Q4 2025.
- Quarterly Treasury Shares fell 29.87% year-over-year to $417772.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $417772.0 (down 29.87% YoY) and the FY2025 annual result came in at $417772.0, down 29.87% from the prior year.
- Treasury Shares slipped to $417772.0 in Q4 2025 per STRO's latest filing, from $5.2 million in the prior quarter.
- Over five years, Treasury Shares peaked at $6.2 million in Q2 2025 and troughed at $417772.0 in Q4 2025.
- A 5-year average of $4.0 million and a median of $3.9 million in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2021 and 2024: Treasury Shares jumped 260.73% in 2021, then plunged 88.64% in 2024.
- Over 5 years, Treasury Shares stood at $2.4 million in 2021, then soared by 64.67% to $4.0 million in 2022, then jumped by 32.5% to $5.2 million in 2023, then slumped by 88.64% to $595691.0 in 2024, then fell by 29.87% to $417772.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $417772.0, $5.2 million, and $6.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | 410,619.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 410,619.00 |
| Jun 30, 2026 | 410,619.00 |
| Dec 31, 2025 | 417,772.00 |
| Dec 31, 2025 | 417,772.00 |
| Sep 30, 2025 | 5.24 Mn |
| Sep 30, 2025 | 5.24 Mn |
| Jun 30, 2025 | 6.25 Mn |
| Jun 30, 2025 | 6.25 Mn |
| Mar 31, 2025 | 3.92 Mn |
| Mar 31, 2025 | 3.92 Mn |
| Dec 31, 2024 | 595,691.00 |
| Dec 31, 2024 | 595,691.00 |
| Sep 30, 2024 | 6.02 Mn |
| Sep 30, 2024 | 6.02 Mn |
| Jun 30, 2024 | 6.05 Mn |
| Jun 30, 2024 | 6.05 Mn |
| Mar 31, 2024 | 6.22 Mn |
| Mar 31, 2024 | 6.22 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Dec 31, 2023 | 5.24 Mn |